共 13 条
- [1] Walsh J.K., Zaleplon, CNS Drugs, 11, 5, (1999)
- [2] Wagner J., Wagner M.L., Hening W.A., Beyond benzodiazepines: Alternative pharmacologic agents for the treatment of insomnia, Ann Pharmacother, 32, pp. 680-691, (1998)
- [3] Beer B., Clody D.E., Mangano R., Et al., A review of the preclinical development of zaleplon, a novel non-benzodiazepine hypnotic for the treatment of insomnia, CNS Drug Rev, 3, 3, pp. 207-224, (1997)
- [4] Hurst M., Noble S., Zaleplon, CNS Drugs, 11, 5, pp. 387-392, (1999)
- [5] Langtry H.D., Benfield P., Zolpidem. A review of its pharmacodynamic and pharmacokinetic properties and therapeutic potential, Drugs, 40, 2, pp. 291-313, (1990)
- [6] Sanger D.J., Depoortere H., The pharmacology and mechanism of action of zolpidem, CNS Drug Rev, 4, 4, pp. 323-340, (1998)
- [7] Physicians' Desk Reference. 52nd Ed., pp. 2275-2278, (1998)
- [8] British National Formulary. No. 37, 37, pp. 159-162, (1999)
- [9] Noble S., Langtry H.D., Lamb H.M., Zopiclone. An update of its pharmacology, clinical efficacy and tolerability in the treatment of insomnia, Drugs, 55, 2, pp. 277-302, (1998)
- [10] Walsh J.K., Fry J., Erwin C.W., Et al., Efficacy and tolerability of 14-day administration of zaleplon 5mg and 10mg for the treatment of primary insomnia, Clin Drug Invest, 16, 5, pp. 347-354, (1998)